Frontlight ResearchEarly access
Trial site
Medical Corporation Chiseikai Tokyo Center Clinic
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Type 2 diabetes3 trials
- Alzheimer disease1 trial
- Phase
- Phase 35 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Amgen1 trial
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026